All lobbying filings

THOLOS GOVERNMENT RELATIONS

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Research, development, and manufacturing of pharmaceutical products

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Sep 16, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Delaware

Official filing document

Lobbyists on this filing 3

ALEIX JARVIS New on this filing

Previously held: Legislative Director, Senator Lindsey Graham; Legislative Director, Rep. Lindsey Graham; Legislative Assistant, Rep. Lindsey Graham; Staff Assistant, Rep. Charles Taylor
MATTHEW JOSEPH SCHUCK New on this filing

Previously held: Communications Dir., House Budget Committee/Rep. Jason Smith; Communications Dir., Rep. Sean Duffy; Press Sec., Rep. Mark Sanford; Dir. of Strategic Communications, HUD; White House Liaison, USAGM
MICHAEL WILLIAMS New on this filing

Previously held: Associate Deputy General Counsel, OMB; Deputy Asst. to President and Counselor to the White House Chief of Staff; Acting General Counsel, Department of Housing and Urban Development

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 3

Pharmacy

Issues related to pharmaceuticals, intellectual property, and trade

Trade (domestic/foreign)

Issues related to pharmaceuticals, intellectual property, and trade

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

ASTRAZENECA PLC

United Kingdom · Cambridge CB2 0AA · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.